different types cryptocurrency, Reviews

Reuters survey: In December, the Bank of England decided to keep interest rates unchanged or cut interest rates by 100 basis points next year. All 71 economists surveyed during December 6-11 predicted that the Bank of England would keep its target interest rate unchanged at 4.75% at its meeting on December 19. Among the economists who predict the interest rate outlook until the end of 2025, about 54% (36 out of 67) expect to cut interest rates by 100 basis points by the end of next year, another 17 expect to cut interest rates by at least 125 basis points, and 14 expect to cut interest rates by at most 75 basis points.In 2023, the trade volume between the mainland and Macao increased by 4.3 times compared with that before the reunification. At the regular press conference held by the Ministry of Commerce today (12th), spokesman He Yadong introduced that by signing CEPA and its series of agreements, the mainland has fully liberalized its trade in goods and basically liberalized its trade in services. According to statistics, in 2023, the trade volume between the mainland and Macao was 3.84 billion US dollars, an increase of 4.3 times compared with that before the reunification. By October 2024, the mainland had absorbed a total of 23.93 billion US dollars of direct investment from Macao, and the mainland had invested 14.19 billion US dollars in Macao.Reuters survey: In December, the Bank of England decided to keep interest rates unchanged or cut interest rates by 100 basis points next year. All 71 economists surveyed during December 6-11 predicted that the Bank of England would keep its target interest rate unchanged at 4.75% at its meeting on December 19. Among the economists who predict the interest rate outlook until the end of 2025, about 54% (36 out of 67) expect to cut interest rates by 100 basis points by the end of next year, another 17 expect to cut interest rates by at least 125 basis points, and 14 expect to cut interest rates by at most 75 basis points.

Meili Technology: Meili, a wholly-owned subsidiary, plans to purchase assets related to MSSC AHLE GmbH for 8.1 million euros. Meili, a wholly-owned subsidiary of Meili Technology, signed an Asset Purchase Agreement with MSSC AHLE GmbH(AHLE Company) on December 10, 2024 to purchase assets related to AHLE Company's business at a transaction consideration of 8.1 million euros, including factory buildings, production equipment, inventory, intangible assets, contractual rights, etc. AHLE Company was established in 1904, and its main business is spring research and development, manufacturing, sales and trade, etc. Its main products include automobile suspension springs, brake chamber springs and recovery springs, and its customers include Volkswagen, ZF and other OEMs and first-class suppliers. Due to operational difficulties, the bankruptcy court in Cologne, Germany, initiated bankruptcy proceedings on the property of AHLE Company on October 1, 2024. Germany Meili purchased these assets by auction, and the transaction price was based on the Financial Due Diligence Report and the Legal Due Diligence Report issued by a third-party intermediary agency, taking into account the market position, channels, customers and future market opportunities of the subject matter of the transaction.In the latest centralized purchase of sitagliptin tablets, the price dropped to less than 20 cents per tablet, with a drop of over 90%. The reporter learned at the scene of the tenth batch of drug centralized purchase that more than 30 companies bid for sitagliptin, which is known as the largest variety in this centralized purchase, including Huahai Pharmaceutical, Kelun Pharmaceutical, Zhengda Tianqing, tonghua dongbao, Zhejiang Pharmaceutical, Jiudian Pharmaceutical, Shiyao Ouyi, Chenxin Pharmaceutical and many other companies. Judging from the bidding results, the lowest bid price among enterprises has dropped below 0.2 yuan per piece, which is more than 90% lower than the limit price. Statistics show that in 2023, the sales of this product in the terminals of public medical institutions in China exceeded 2 billion yuan, and the sales of Merck, the original research manufacturer, accounted for more than 90%, so there is a large room for generic drug substitution. The quotation of Meradong in this collection is about 7.37 yuan per piece. (science and technology innovation board Daily)Ai Kelan: Liu Yi, the actual controller, intends to transfer 5% of the company's shares by agreement, with a total transaction price of 82.44 million yuan. Liu Yi, the controlling shareholder and actual controller, signed a share transfer agreement with Guangdong Nanchuan Private Equity Fund Management Co., Ltd., and Liu Yi intends to transfer 4 million unrestricted shares of the company (accounting for 5% of the company's total share capital) to Nanchuan Private Equity through agreement transfer. The transfer price is 20.61 yuan per share, and the total transaction price is 82.44 million yuan. This change in equity will not lead to changes in the controlling shareholder or actual controller of the company, and will not lead to changes in the control rights of listed companies.

The Polish minister said that Poland hopes that more countries will participate in Baltic policing, the EU must spend at least 100 billion euros on national defense, and the conditions for sending Polish MIG -29 fighters to Ukraine have not been met.President of the Swiss National Bank: We will continue to monitor inflationary pressure and adjust monetary policy to maintain price stability if necessary. The president of the Swiss National Bank said that we will continue to monitor inflationary pressure and adjust monetary policy to maintain price stability if necessary. If there is no interest rate cut today, inflation expectations will be lower; The uncertainty of the future inflation path is still high.Qianjin Pharmaceutical Co., Ltd.: The subsidiary company obtained the dapoxetine hydrochloride Pharmaceutical Registration Certificate, and Qianjin Pharmaceutical announced that Qianjin Xiangjiang Pharmaceutical Co., Ltd. received the dapoxetine hydrochloride Pharmaceutical Registration Certificate approved and issued by National Medical Products Administration. The medicine is suitable for the treatment of male premature ejaculation patients aged 18 to 64.